Caplin Point Laboratories Limited (BOM:524742)
India · Delayed Price · Currency is INR 2,381.35
-41.20 (-1.70%)
At close: Nov 6, 2026
Caplin Point Laboratories Market Cap
Caplin Point Laboratories has a market cap or net worth of 181.01 billion as of November 6, 2026. It is the 6,662nd most valuable company in the world and the 389th biggest in India. Its market cap has increased by 19.11% in one year.
Market Cap
181.01B
Enterprise Value
172.18B
Revenue
22.87B
Global Rank
Country Rank
#389 India
PE Ratio
27.28
ChartMarket Cap Chart
Since February 26, 2002, Caplin Point Laboratories's market cap has increased from 5.60M to 181.01B, an increase of 3,232,806.81%. That is a compound annual growth rate of 52.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 181.01B | 29.34% |
| Dec 31, 2025 | 139.95B | -26.39% |
| Dec 31, 2024 | 190.12B | 84.60% |
| Dec 29, 2023 | 102.99B | 90.47% |
| Dec 30, 2022 | 54.07B | -16.82% |
| Dec 31, 2021 | 65.01B | 69.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Abbott India | 576.85B |
| GlaxoSmithKline Pharmaceuticals | 429.04B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Granules India | 196.89B |
| AstraZeneca Pharma India | 159.13B |
| Jubilant Pharmova | 148.80B |
| Viyash Scientific | 100.87B |
| Procter & Gamble Health | 94.75B |